HK Stock MarketDetailed Quotes

SINOMAB BIO-B (03681)

Watchlist
  • 1.410
  • -0.020-1.40%
Market Closed May 6 15:58 CST
1.96BMarket Cap-16.79P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

SINOMAB BIO-B (03681) Income Statement

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q6)Jun 30, 2025
(FY)Dec 31, 2024
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
Turnover
----
----
48.42%2.03M
48.42%2.03M
--1.37M
--1.37M
----
----
--25.91M
----
Operating income
48.42%2.03M
48.42%2.03M
1.37M
1.37M
25.91M
Cost of sales
----
----
-57.26%-1.48M
-57.26%-1.48M
---943K
---943K
----
----
----
----
Operating expenses
-57.26%-1.48M
-57.26%-1.48M
-943K
-943K
Gross profit
28.67%543K
28.67%543K
422K
422K
Administrative expenses
31.50%-46.38M
30.61%-23.73M
30.63%-67.72M
31.86%-34.21M
-18.19%-97.62M
-48.31%-50.2M
38.09%-82.59M
-3.01%-33.85M
-85.25%-133.4M
34.32%-32.86M
Research and development expenses
13.86%-81.62M
40.51%-32.74M
30.02%-94.75M
17.55%-55.04M
24.93%-135.41M
18.73%-66.75M
9.41%-180.37M
8.73%-82.13M
-92.56%-199.11M
-88.18%-89.98M
Operating interest expense
----
----
----
----
----
----
----
14.37%-2.14M
-140.94%-5.82M
-63.98%-2.5M
Special items of operating profit
296.16%28.55M
608.00%9.64M
-270.80%-14.55M
109.48%1.36M
63.79%-3.93M
36.09%-14.37M
-138.02%-10.84M
-278.31%-22.48M
-49.06%28.52M
-31.96%12.61M
Operating profit
43.64%-99.46M
46.38%-46.83M
25.39%-176.48M
33.28%-87.34M
13.61%-236.53M
6.90%-130.89M
3.56%-273.8M
-24.72%-140.6M
-132.99%-283.91M
-39.45%-112.74M
Financing cost
36.20%-5.53M
9.04%-2.99M
-31.55%-8.66M
-2.65%-3.29M
-32.69%-6.58M
---3.2M
---4.96M
----
----
----
Share of profits of associates
----
----
----
----
----
----
-25.81%-5.4M
-91.31%-3.19M
-474.16%-4.29M
---1.67M
Earning before tax
43.29%-104.99M
45.02%-49.82M
23.85%-185.14M
32.42%-90.62M
14.45%-243.11M
6.74%-134.1M
1.40%-284.16M
-25.69%-143.79M
-135.07%-288.19M
-41.52%-114.4M
After-tax profit from continuing operations
43.29%-104.99M
45.02%-49.82M
23.85%-185.14M
32.42%-90.62M
14.45%-243.11M
6.74%-134.1M
1.40%-284.16M
-25.69%-143.79M
-135.07%-288.19M
-41.52%-114.4M
Earning after tax
43.29%-104.99M
45.02%-49.82M
23.85%-185.14M
32.42%-90.62M
14.45%-243.11M
6.74%-134.1M
1.40%-284.16M
-25.69%-143.79M
-135.07%-288.19M
-41.52%-114.4M
Profit attributable to shareholders
43.29%-104.99M
45.02%-49.82M
23.85%-185.14M
32.42%-90.62M
14.45%-243.11M
6.74%-134.1M
1.40%-284.16M
-25.69%-143.79M
-135.07%-288.19M
-41.52%-114.4M
Basic earnings per share
47.06%-0.09
37.50%-0.05
29.17%-0.17
38.46%-0.08
17.24%-0.24
13.33%-0.13
0.00%-0.29
-36.36%-0.15
-141.67%-0.29
-37.50%-0.11
Diluted earnings per share
47.06%-0.09
37.50%-0.05
29.17%-0.17
38.46%-0.08
17.24%-0.24
13.33%-0.13
0.00%-0.29
-36.36%-0.15
-141.67%-0.29
-37.50%-0.11
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
Unqualified Opinion
--
--
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Auditor
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
(FY)Dec 31, 2025(Q6)Jun 30, 2025(FY)Dec 31, 2024(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021
Turnover --------48.42%2.03M48.42%2.03M--1.37M--1.37M----------25.91M----
Operating income 48.42%2.03M48.42%2.03M1.37M1.37M25.91M
Cost of sales ---------57.26%-1.48M-57.26%-1.48M---943K---943K----------------
Operating expenses -57.26%-1.48M-57.26%-1.48M-943K-943K
Gross profit 28.67%543K28.67%543K422K422K
Administrative expenses 31.50%-46.38M30.61%-23.73M30.63%-67.72M31.86%-34.21M-18.19%-97.62M-48.31%-50.2M38.09%-82.59M-3.01%-33.85M-85.25%-133.4M34.32%-32.86M
Research and development expenses 13.86%-81.62M40.51%-32.74M30.02%-94.75M17.55%-55.04M24.93%-135.41M18.73%-66.75M9.41%-180.37M8.73%-82.13M-92.56%-199.11M-88.18%-89.98M
Operating interest expense ----------------------------14.37%-2.14M-140.94%-5.82M-63.98%-2.5M
Special items of operating profit 296.16%28.55M608.00%9.64M-270.80%-14.55M109.48%1.36M63.79%-3.93M36.09%-14.37M-138.02%-10.84M-278.31%-22.48M-49.06%28.52M-31.96%12.61M
Operating profit 43.64%-99.46M46.38%-46.83M25.39%-176.48M33.28%-87.34M13.61%-236.53M6.90%-130.89M3.56%-273.8M-24.72%-140.6M-132.99%-283.91M-39.45%-112.74M
Financing cost 36.20%-5.53M9.04%-2.99M-31.55%-8.66M-2.65%-3.29M-32.69%-6.58M---3.2M---4.96M------------
Share of profits of associates -------------------------25.81%-5.4M-91.31%-3.19M-474.16%-4.29M---1.67M
Earning before tax 43.29%-104.99M45.02%-49.82M23.85%-185.14M32.42%-90.62M14.45%-243.11M6.74%-134.1M1.40%-284.16M-25.69%-143.79M-135.07%-288.19M-41.52%-114.4M
After-tax profit from continuing operations 43.29%-104.99M45.02%-49.82M23.85%-185.14M32.42%-90.62M14.45%-243.11M6.74%-134.1M1.40%-284.16M-25.69%-143.79M-135.07%-288.19M-41.52%-114.4M
Earning after tax 43.29%-104.99M45.02%-49.82M23.85%-185.14M32.42%-90.62M14.45%-243.11M6.74%-134.1M1.40%-284.16M-25.69%-143.79M-135.07%-288.19M-41.52%-114.4M
Profit attributable to shareholders 43.29%-104.99M45.02%-49.82M23.85%-185.14M32.42%-90.62M14.45%-243.11M6.74%-134.1M1.40%-284.16M-25.69%-143.79M-135.07%-288.19M-41.52%-114.4M
Basic earnings per share 47.06%-0.0937.50%-0.0529.17%-0.1738.46%-0.0817.24%-0.2413.33%-0.130.00%-0.29-36.36%-0.15-141.67%-0.29-37.50%-0.11
Diluted earnings per share 47.06%-0.0937.50%-0.0529.17%-0.1738.46%-0.0817.24%-0.2413.33%-0.130.00%-0.29-36.36%-0.15-141.67%-0.29-37.50%-0.11
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions Unqualified Opinion------Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--
Auditor Ernst & Young--Ernst & Young--Ernst & Young--Ernst & Young--Ernst & Young--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +8.45%
Sample Name
Sample Code
 +4.80%
Sample Name
Sample Code
 +3.86%
4
CNOOC
00883
+3.77%
5
SINOPEC CORP
00386
+2.61%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +61.02%
Sample Name
Sample Code
 +51.07%
Sample Name
Sample Code
 +40.94%
4
Business-intelligence Of Oriental Nations Corporation
300166
+33.12%
5
Emdoor Information
001314
+32.98%
View More
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -